Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

BACKGROUND: While programmed death 1 (PD-1) and programmed death-ligand 1 (PD-L1) checkpoint inhibitors have activity in a proportion of patients with advanced bladder cancer, strongly predictive and prognostic biomarkers are still lacking. In this study, we evaluated PD-L1 protein expression on cir...

Descripción completa

Detalles Bibliográficos
Autores principales: Anantharaman, Archana, Friedlander, Terence, Lu, David, Krupa, Rachel, Premasekharan, Gayatri, Hough, Jeffrey, Edwards, Matthew, Paz, Rosa, Lindquist, Karla, Graf, Ryon, Jendrisak, Adam, Louw, Jessica, Dugan, Lyndsey, Baird, Sarah, Wang, Yipeng, Dittamore, Ryan, Paris, Pamela L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034508/
https://www.ncbi.nlm.nih.gov/pubmed/27658492
http://dx.doi.org/10.1186/s12885-016-2758-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034508/
https://www.ncbi.nlm.nih.gov/pubmed/27658492
http://dx.doi.org/10.1186/s12885-016-2758-3

Ejemplares similares